EAU 2022: Metastatic Prostate Cancer: Possible Synergies Between Radioligand and Systemic Treatment in M1 Prostate Cancer? Future Perspectives
2022 EAU modern diagnostic and therapeutic approaches in prostate cancer, future perspectives for possible synergies between radioligand and systemic treatment in M1 prostate cancer, The VISION study prostate cancer